Companies / Hungary

Polpharma Pulls Out Of Merger With Gedeon Richter

July 2008 | Company News Alert

Printable version
Bookmark

Puls Biznesu reported that the merger agreement between Polpharma and Gedeon Richter failed after Polpharma's parent Genefar pulled out of their merger agreement.

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Forecast Maintained: Moderate Growth To Continue

Industry / Hungary BMI View: BMI's projection that Hungary will achieve only marginal pharmaceutical market growth in 2010 has been confirmed. Supported by our latest macroeconomic forecasts, our long-term outlook for Hungary's...

December 2010

Richter Enters Commoditised Generics Sector With Astron Collaboration

Industry / Hungary Gedeon Richter has entered a collaboration agreement with Indian firm Astron Research to develop and expand the Hungarian firm's portfolio of generic drugs. Richter claims the deal allows it to continue...

March 2010

Egis To Rival Richter In Biosimilars Market

Industry / Hungary Hungarian generics firm Egis has acquired distribution rights for biosimilar products from South Korean biotechnology company Celltrion across markets in Central and Eastern Europe (CEE), including the...

February 2010

Drugmakers Increasingly Subsidising OEP

Industry / Hungary Drugmakers operating in Hungary will have to stump up higher-than-expected levels of subsidies to the National Health Insurance Fund (OEP), based on trends witnessed in the first nine months of 2009....

October 2009

Sales Representative Fee To Be Reintroduced, 12% Revenue Tax Remains

Industry / Hungary The 12% tax that drug manufacturers pay on revenues for reimbursed drugs in Hungary is to stay, and there will be a push to reintroduce the annual HUF5mn (US$29,958) registration fee for medical representatives,...

September 2008